Distalmotion

Distalmotion

Pre-clinical
Lausanne, SwitzerlandFounded 2012distalmotion.com

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

Founded
2012
Employees
150+
Focus
Medical Devices

AI Company Overview

Distalmotion is a privately held medical device company headquartered in Lausanne, Switzerland, with a mission to empower access to robotic surgery by removing operational barriers. The company's flagship product, the DEXTER Robotic Surgery System, is designed for seamless integration into existing operating room workflows, enabling more surgeons across more care sites to perform robotic procedures. Having received CE mark in 2020 and FDA clearances for specific procedures, DEXTER is now in clinical use, treating patients daily. The company employs over 150 people from more than 25 nationalities, united in bringing best-in-class minimally invasive surgical care to patients worldwide.

Technology Platform

The DEXTER Robotic Surgery System is a modular, hybrid platform designed to simplify robotic-assisted minimally invasive surgery by integrating seamlessly into existing operating room workflows, allowing surgeons to switch between laparoscopic and robotic techniques.

Funding History

3

Total raised: $95M

Series C$45MEndeavour VisionSep 15, 2020
Series B$30MEndeavour VisionApr 15, 2018
Series A$20MEndeavour VisionMay 15, 2016

Opportunities

The primary growth opportunity lies in expanding robotic surgery into community hospitals and ambulatory surgery centers by lowering cost and complexity barriers.
Leveraging the high-volume procedures for which DEXTER is cleared (hernia, gallbladder, benign hysterectomy) provides a substantial addressable market.
Further geographic expansion and securing additional regulatory clearances for new procedures on the same platform represent additional avenues for growth.

Risk Factors

Key risks include intense competition from well-funded giants like Intuitive Surgical, the challenge of building sufficient clinical evidence and market traction to drive adoption, potential reimbursement hurdles, and the execution risks associated with scaling a capital-intensive hardware business globally.

Competitive Landscape

Distalmotion competes in the surgical robotics market dominated by Intuitive Surgical. Its main differentiation is focused on simplifying operations and reducing workflow disruption to enable access in more care settings, contrasting with larger, more complex systems. It also faces competition from other new entrants like Medtronic, Johnson & Johnson, and CMR Surgical.

Company Info

TypePlatform
Founded2012
Employees150+
LocationLausanne, Switzerland
StagePre-clinical
RevenueEarly Revenue

Therapeutic Areas

General SurgeryGynecologyUrology

Partners

Swiss Federal Institute of Technology in Lausanne (EPFL) - Robotics Lab (spin-off origin)
SIMILAR COMPANIES
3Brain
3Brain
Pre-clinical · Zug
Baxiva
Baxiva
Pre-clinical · Zug
AC Bioscience
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
AdipoGen
Pre-clinical · Liestal
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile